Inhibition of the B cell by CD22: A requirement for Lyn

被引：163

作者：

Smith, KGC

Tarlinton, DM

Doody, GM

Hibbs, ML

Fearon, DT ^{[1
]}

机构：

[1] Univ Cambridge, Sch Clin Med, Dept Med, Wellcome Trust Immunol Unit, Cambridge CB2 2SP, England

[2] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia

[3] Royal Melbourne Hosp, Ludwig Inst Canc Res, Tumor Biol Branch, Parkville, Vic 3050, Australia

来源：

JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 187卷 / 05期

基金：

英国惠康基金;

关键词：

D O I：

10.1084/jem.187.5.807

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Mice in which the Lyn, Cd22, or Shp-1 gene has been disrupted have hyperactive B cells and autoantibodies. We find that in the absence of Lyn, the ability of CD22 to become tyrosine phosphorylated after Ligation of mIg, to recruit SHP-1, and to suppress mig-induced elevation of intracellular [Ca2+] is lost. Therefore, Lyn is required for the SHP-1-mediated B cell suppressive function of CD22, accounting for similarities in the phenotypes of these mice.

引用

页码：807 / 811

页数：5

共 50 条

[1] Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway
Cornall, RJ
Goodnow, CC
Cyster, JG
IMMUNORECEPTOR TYROSINE-BASED INHIBITION MOTIFS, 1999, 244 : 57 - 68
[2] Dendritic cell-dependent inhibition of B cell proliferation requires CD22
Santos, Lorna
Draves, Kevin E.
Boton, Mark
Grewal, Prabhjit K.
Marth, Jamey D.
Clark, Edward A.
JOURNAL OF IMMUNOLOGY, 2008, 180 (07): : 4561 - 4569
[3] Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival
Ferry, H
Cockford, TL
Silver, K
Rust, N
Goodnow, CC
Cornall, RJ
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (12) : 3655 - 3663
[4] STALing B cell responses with CD22
Chappell, Craig P.
Clark, Edward A.
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (07): : 2778 - 2780
[5] Analysis of murine CD22 during B cell development: CD22 is expressed on B cell progenitors prior to IgM
Stoddart, A
Ray, RJ
Paige, CJ
INTERNATIONAL IMMUNOLOGY, 1997, 9 (10) : 1571 - 1579
[6] Regulation of the B cell antigen receptor by CD22
Otipoby, KL
Draves, KE
Clark, EA
FASEB JOURNAL, 1998, 12 (05): : A916 - A916
[7] Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model
Bednar, Kyle J.
Shanina, Elena
Ballet, Romain
Connors, Edward P.
Duan, Shiteng
Juan, Joana
Arlian, Britni M.
Kulis, Michael D.
Butcher, Eugene C.
Fung-Leung, Wai-Ping
Rao, Tadimeti S.
Paulson, James C.
Macauley, Matthew S.
JOURNAL OF IMMUNOLOGY, 2017, 199 (09): : 3116 - 3128
[8] Cullin 3 Is Crucial for Pro-B Cell Proliferation, Interacts with CD22, and Controls CD22 Internalization on B Cells
Meyer, Sarah J.
Boser, Alexander
Korn, Marina A.
Koller, Claudia
Bertocci, Barbara
Reimann, Lena
Warscheid, Bettina
Nitschke, Lars
JOURNAL OF IMMUNOLOGY, 2020, 204 (12): : 3360 - 3374
[9] Targeting CD22 for B-cell hematologic malignancies
Xu, Jia
Luo, Wenjing
Li, Chenggong
Mei, Heng
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
[10] Sialoside regulation of B cell function through CD22
Collins, BE
Nitschke, L
Marth, JD
Paulson, JC
GLYCOBIOLOGY, 2003, 13 (11) : 884 - 884

← 1 2 3 4 5 →